FDA granted Juul marketing approval for e-cigarettes, raising competitive pressure on Altria's nicotine alternatives portfolio.
4 reports, 4 independent
Updated Aug 28
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted Juul marketing approval for e-cigarettes, raising competitive pressure on Altria's nicotine alternatives portfolio.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Altria is under investigation by the FDA regarding the misrepresentation of its product's regulatory status.Sub-event
Juul's FDA approval intensifies competition for Altria, leading to NJOY sales halts.1 source
Keep exploring
The entities involved
-
Altria
American multinational company
-
Juul
American electronic cigarette manufacturer
Nothing else this week.
- FDA
Related events
- Tightening regulations on tobacco sales were reported involving Altria and Marlboro.
- Rivalry in the adult nicotine consumer market as companies seek federal permission for updated e-cigarette sales.
- Juul is currently trailing Reynolds American in market share, while the FDA has granted permission for updated e-cigarette sales.
Coverage
Newest first; wire copies grouped- winnipegfreepress.com
- BarchartThe FDA Just Approved Juul’s E-Cigarettes. Does That Make Altria Stock a Buy Here? Following a prolonged and high-stakes legal battle, the U.S. Food and Drug Administration (FDA) granted Juul marketi
- BenzingaThe Vaping Giant That Almost Died: JUUL's Shocking FDA Reversal In a significant reversal and a major boost for the embattled vaping company, the U.S. Food and Drug Administration (FDA) on Thursday a
- GlobeNewswireCEA Industries Applauds FDA Authorization of JUUL Products, Signals Opportunity for U.S. Market Expansion Louisville, Colorado, July 18, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: VAPE) (“